Key Market Indicators
Greek sales of antihypertensive medicines are forecast to decline slightly from $38.06 million in 2021 to $36.7 million by 2026. This decrease of 0.1% per year is lower than the 5.7% year-on-year growth since 2003. In 2021, Greece ranked ninth in global sales of antihypertensive medicines, just behind Austria with $38.06 million. Italy, Spain, and Australia followed as the second, third, and fourth largest markets respectively.
